Schedule 13G ownership disclosure

ABBVIE INC COM

Common Stock · CUSIP: 00287Y109

Event date: 2025-06-30

Filing-level shares
177,266,703
Percent of class
10.03%
  • The Vanguard Group

    Shares: 177,266,703 · Class: 10.03%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000695
Form type
SCHEDULE 13G/A
Filer
AbbVie Inc.
CIK
CIK 1551152
Filed
Jul 07, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub